Prof. Tzipora C. Falik-Zaccai

עברית Tell a Friend
Vice Dean, Medical Research
Academic field
Research field
Galilee Medical Center, Nahariya

Prof. Tzipora C. Falik-Zaccai is an Associate Professor of Medical Genetics & Pediatrics and the founder and Director of the Institute of Human Genetics at the Galilee Medical Center, The Azrieli Faculty of Medicine, Bar-Ilan University.

Board certified in Pediatrics (Israel) and Medical Genetics (Israel and the USA), she is a member of the R&D committee and Ethics committee at The Galilee Medical Center where she was elected as the outstanding physician for the year 2009.

Prof. Tzipora Falik-Zaccai serves a variety of roles in the Azrieli Faculty of Medicine-Bar Ilan: She is the vice dean for medical research and directing the MD PhD program for excellent students, and the human genetic department at the Faculty. She is the mentor of post graduate students and residents in basic science projects.

Prof. Falik-Zaccai has directed her research toward the identification of the causative genes of rare genetic diseases. She and her team also devote their time towards the development of tailored genetic counseling in different ethnic groups, at high risk for genetic disorders and birth defects. This service is aimed at educating, preventing and minimizing the personal burden of birth defects and rare disorders for the benefit of all ethnic communities in Northern Israel. She was honored to open a research center for the study of human genetic diseases granted to Bar Ilan University by Teva pharmaceuticals. Prof. Falik-Zaccai has published many scientific papers in various leading international Journals in the field of Pediatrics, Medical and Molecular Genetics and presented her work in national and international meetings.




Main Research Interests and Achievements


 The clinical, biochemical and molecular characterization and identification of genes responsible for rare genetic diseases. Diseases currently of particular interest are Gray platelet syndrome, Aplasia of distal phalanges with juvenile breast hypertrophy, Osteogenesis imperfecta and neurogenetic diseases; Hereditary Spastic Paraparesis, and more

Identification of new mutations, genes and proteins involved in NER type DNA repair mechanisms. Understanding their cellular function and their role in premature aging and cancer. In addition, the establishment of new diagnostic procedures for the screening of causative mutations in the patient population in Israel and the Middle East


Development of methods of genetic counseling tailored to kindreds at high risk for genetic disorders, in an attempt to raise awareness, and to prevent and minimize the births of affected individuals. Also, early identification of affected newborns is critical for provision of prompt and effective treatment


Genetics of pain: Our interest in this field is manifested in the study of women with dyspareunia  (pain during sexual intercourse). This phenomenon is evident within families, and genetic associations have been found. With the collaboration of Prof. J. Bornstein, we are studying possible genetic associations that relate to biochemical pathways involved in pain regulation among a large cohort of women affected with vulvodynia



1. NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet α-granules. Gunay-Aygun M. et al. Nat Genet. 2011


2. Gray platelet syndrome: natural history of a large patient cohort and locus assignment to chromosome 3p. Gunay-Aygun M et al. Blood. 2010

3. Mammary-digital-nail (MDN) syndrome: a novel phenotype maps to human chromosome 22q12.3-13.1.Genzer-Nir M. et al. Eur J Hum Genet. 2010


4. The versatile DNA nucleotide excision repair (NER) and its medical significance. Falik-Zaccai TC, Keren Z, Slor H. Pediatr Endocrinol Rev. 2009


5. Prolidase deficiency: it looks like systemic lupus erythematosus but it is not. Klar A, et al. Eur J Pediatr. 2010


6. Cerebrotendinous xanthomatosis (CTX): a treatable lipid storage disease. Keren Z, Falik-Zaccai TC. Pediatr Endocrinol Rev. 2009


7. A broad spectrum of developmental delay in a large cohort of prolidase deficiency patients demonstrates marked interfamilial and intrafamilial phenotypic variability. Falik-Zaccai TC, et al. Am J Med Genet B Neuropsychiatr Genet. 2010


8. Dynamic modification strategy of the Israeli carrier screening protocol: inclusion of the Oriental Jewish Group to the cystic fibrosis panel. Reish O, et al. Genet Med. 2009


9. Skoura - a genetic island for congenital insensitivity to pain and anhidrosis among Moroccan Jews, as determined by a novel mutation in the NTRK1 gene. Suriu C, et al. Clin Genet. 2009


10. Population screening in a Druze community: the challenge and the reward. Falik-Zaccai TC, et al. Genet Med. 2008


11. PNPO deficiency: an under diagnosed inborn error of pyridoxine metabolism. Khayat M, et al. Mol Genet Metab. 2008


12. Cockayne syndrome type II in a Druze isolate in Northern Israel in association with an insertion mutation in ERCC6. Falik-Zaccai TC, et al. Am J Med Genet A. 2008